| Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder N Eissa, M Al-Houqani, A Sadeq, SK Ojha, A Sasse, B Sadek Frontiers in neuroscience 12, 304, 2018 | 270 | 2018 |
| Role of neuroinflammation in autism spectrum disorder and the emergence of brain histaminergic system. Lessons also for BPSD? N Eissa, A Sadeq, A Sasse, B Sadek Frontiers in pharmacology 11, 886, 2020 | 90 | 2020 |
| The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism N Eissa, P Jayaprakash, S Azimullah, SK Ojha, M Al-Houqani, FY Jalal, ... Scientific reports 8 (1), 13077, 2018 | 84 | 2018 |
| The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium … N Eissa, S Azimullah, P Jayaprakash, RL Jayaraj, D Reiner, SK Ojha, ... Chemico-biological interactions 312, 108775, 2019 | 62 | 2019 |
| The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic … N Eissa, S Azimullah, P Jayaprakash, RL Jayaraj, D Reiner, SK Ojha, ... International journal of molecular sciences 21 (11), 3996, 2020 | 38 | 2020 |
| Simultaneous Blockade of Histamine H3 Receptors and Inhibition of Acetylcholine Esterase Alleviate Autistic-Like Behaviors in BTBR T+ tf/J Mouse Model of Autism N Eissa, P Jayaprakash, H Stark, D Łażewska, K Kieć-Kononowicz, ... Biomolecules 10 (9), 1251, 2020 | 33 | 2020 |
| The histamine H3 receptor antagonist DL77 ameliorates MK801-induced memory deficits in rats N Eissa, N Khan, SK Ojha, D Łazewska, K Kieć-Kononowicz, B Sadek Frontiers in neuroscience 12, 42, 2018 | 33 | 2018 |
| Revisiting preclinical observations of several histamine H3 receptor antagonists/inverse agonists in cognitive impairment, anxiety, depression, and sleep–wake cycle disorder M Alhusaini, N Eissa, AK Saad, R Beiram, B Sadek Frontiers in Pharmacology 13, 861094, 2022 | 27 | 2022 |
| The Multi-Targeting Ligand ST-2223 with Histamine H3 Receptor and Dopamine D2/D3 Receptor Antagonist Properties Mitigates Autism-Like Repetitive … N Eissa, K Venkatachalam, P Jayaprakash, M Falkenstein, M Dubiel, ... International journal of molecular sciences 22 (4), 1947, 2021 | 27 | 2021 |
| The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+ tf/J mice by multiple actions K Venkatachalam, N Eissa, M Al Awad, P Jayaprakash, S Zhong, ... Biomedicine & Pharmacotherapy 138, 111517, 2021 | 26 | 2021 |
| Evaluation of certain pharmaceutical quality attributes of lisinopril split tablets KMS Fahelelbom, MMM Al-Tabakha, NAM Eissa, J Javadi Scientia Pharmaceutica 84 (4), 646-653, 2016 | 25 | 2016 |
| The journey of boswellic acids from synthesis to pharmacological activities EA Ragab, MF Abd El-Wahab, AS Doghish, RM Salama, N Eissa, ... Naunyn-schmiedeberg's Archives of Pharmacology 397 (3), 1477-1504, 2024 | 24 | 2024 |
| Development and validation of an RP-HPLC analytical method for determination of lisinopril in full and split tablets K Fahelelbom, MMM Al-Tabakha, NAM Eissa, DEE Obaid, S Sayed Research Journal of Pharmacy and Technology 13 (6), 2647-2652, 2020 | 12 | 2020 |
| Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice N Eissa, MA Awad, SD Thomas, K Venkatachalam, P Jayaprakash, ... International Journal of Molecular Sciences 24 (1), 526, 2023 | 8 | 2023 |
| Targeting microglia in neuroinflammation: H3 receptor antagonists as a novel therapeutic approach for Alzheimer’s disease, Parkinson’s disease, and autism spectrum disorder SD Thomas, S Abdalla, N Eissa, A Akour, NK Jha, S Ojha, B Sadek Pharmaceuticals 17 (7), 831, 2024 | 7 | 2024 |
| Experimental studies indicate that ST-2223, the antagonist of histamine H3 and dopamine D2/D3 receptors, restores social deficits and neurotransmission dysregulation in mouse … N Eissa, K Venkatachalam, P Jayaprakash, P Yuvaraju, M Falkenstein, ... Pharmaceuticals 15 (8), 929, 2022 | 7 | 2022 |
| Quality control of certain slimming herbal products present in the Egyptian market MAA Kawy, EG Haggag, AAA Motaal, NA Eissa Life Science Journal 9 (3), 2012 | 5 | 2012 |
| Decoding the secrets of longevity: unraveling nutraceutical and miRNA-Mediated aging pathways and therapeutic strategies RM Salama, N Eissa, AS Doghish, AI Abulsoud, NM Abdelmaksoud, ... Frontiers in Aging 5, 1373741, 2024 | 4 | 2024 |
| The potent and selective histamine H3 receptor antagonist E169 counteracts cognitive deficits and mitigates disturbances in the PI3K/AKT/GSK-3β signaling pathway in MK801 … S Abdalla, N Eissa, P Jayaprakash, R Beiram, KJ Kuder, D Łażewska, ... International journal of molecular sciences 24 (16), 12719, 2023 | 4 | 2023 |
| Structure‐based drug design and in vitro testing reveal new inhibitors of enoyl‐acyl carrier protein reductases MA Ghattas, NA Eissa, F Tessaro, R Perozzo, L Scapozza, D Obaid, ... Chemical biology & drug design 94 (2), 1545-1555, 2019 | 4 | 2019 |
Bassem Shaban SadekProfessor, Department of Pharmacology and Therapeutics, United Arab Emirates Universityuaeu.ac.ae üzerinde doğrulanmış e-posta adresine sahip
